NCT01328938 - GCPGC in Chemotherapy-induced Neutropenia | Biotech Hunter

Enrollment

177

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

May 31, 2013

Conditions

Chemotherapy Induced Neutropenia

Interventions

BIOLOGICAL

GCPGC 3.6mg

Stage I:Single blinded

BIOLOGICAL

GCPGC 6mg

Stage I: Single blinded;

BIOLOGICAL

Neulasta (pegfilgrastim) 6mg

Stage II: Active comparator, double blinded

BIOLOGICAL

GCPGC 6mg

Experimental: Stage II

Trial Locations (15)

Chungbuk National University Hospital, Chungju

National Cancer Center, Ilsan

Gachon University Gil Hospital, Incheon

Seoul National University Bundang Hospital, Sungnam

Keimyung University Dongsan medical Center, Daegu

Pusan National University Hospital, Pusan

Chung-Ang University Hospital, Seoul

Inha University Hospital, Seoul

Konkuk University Medical Center, Seoul

Kyung Hee University Medical Center, Seoul

Seoul Asan Medical Center, Seoul

Seoul National University Hospital, Seoul

Seoul St.Mary's Hospital, Seoul

SMG-SNU Boramae Medical Center, Seoul

Ulsan University Hospital, Ulsan